StudyFinder
Neurodevelopmental Outcomes for CMV Infections Identified by Newborn Screening
Status: Recruiting
This research study is about early development in children diagnosed with congenital cytomegalovirus infection (cCMV), identified by newborn screening that has been confirmed with a follow-up test. Study visits, when the child is 12, 24 and 36 months of age, will include questionnaires, direct assessment of child and interviews with parent(s). A brain MRI will also be completed at about 12 months. Parents will receive a report summarizing a child’s developmental, language, and behavioral assessments, reported as within normal ranges or if clinical follow-up is recommended.
Sex: Male or Female
Age Group: Up to 18 years old
Inclusion Criteria:
• less than 14 months old
• tested positive for congenital cytomegalovirus (also called cCMV or CMV) on the newborn heel / blood spot screening test
• parent/guardian is able to complete study visits, interviews and questionnaires in English
Exclusion Criteria:
• certain medical conditions that study staff will screen for during the process of joining the study
Conditions:
Brain & Nervous System, Children's Health, Infectious Diseases
Keywords:
Cytomegalovirus, CMV, Sensorineural hearing loss, Infant, Baby
Study Contact: Maya Dosembet - mdos008@umn.edu
Principal Investigator: Meghan Swanson
IRB Number: STUDY00026268